Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 12401-12450 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04565899
Improving Care for Unhealthy Alcohol Use in Primary Care
NA
Active, not recruiting
42 participants
Started: Feb 25, 2021 · Completed: Sep 30, 2025
2 conditions
1 sponsor
2 locations
NCT04586231
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
PHASE3
Active, not recruiting
708 participants
Started: Feb 25, 2021 · Completed: Feb 11, 2027
1 condition
2 sponsors
184 locations
NCT04647526
Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment
PHASE3
Active, not recruiting
415 participants
Started: Feb 25, 2021 · Completed: Mar 31, 2028
1 condition
1 sponsor
54 locations
NCT04645693
The Impact of Oral Health in HIV Patients on Antiretroviral Therapy
N/A
Active, not recruiting
350 participants
Started: Feb 24, 2021 · Completed: Mar 31, 2026
5 conditions
2 sponsors
1 location
NCT04699188
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
PHASE1/PHASE2
Active, not recruiting
344 participants
Started: Feb 24, 2021 · Completed: Aug 26, 2026
10 conditions
1 sponsor
37 locations
NCT04696731
Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
PHASE1
Active, not recruiting
120 participants
Started: Feb 24, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
10 locations
NCT04788823
The Impact of Prednisone on Semen Parameters and Pregnancy Rates Post Vasectomy Reversal
PHASE4
Active, not recruiting
100 participants
Started: Feb 24, 2021 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT04674813
A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma
PHASE1
Active, not recruiting
180 participants
Started: Feb 24, 2021 · Completed: Dec 8, 2025
1 condition
1 sponsor
10 locations
NCT04559139
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer
PHASE2/PHASE3
Active, not recruiting
186 participants
Started: Feb 24, 2021 · Completed: Jun 30, 2029
6 conditions
2 sponsors
367 locations
NCT04760769
Open-label Trial in Parkinson's Disease (PD)
PHASE3
Active, not recruiting
992 participants
Started: Feb 24, 2021 · Completed: Jan 31, 2026
1 condition
1 sponsor
140 locations
NCT04777422
Defibrotide in Children With High Risk Kawasaki Disease
PHASE2
Active, not recruiting
2 participants
Started: Feb 24, 2021 · Completed: Jun 30, 2024
1 condition
4 sponsors
3 locations
NCT04943328
Cemented TrendHip® - Multicenter PMCF Study on Total Indications
NA
Active, not recruiting
119 participants
Started: Feb 23, 2021 · Completed: May 8, 2028
6 conditions
1 sponsor
4 locations
NCT04745689
Study of AZD2811 + Durvalumab in ES-SCLC
PHASE2
Active, not recruiting
31 participants
Started: Feb 23, 2021 · Completed: Dec 1, 2025
1 condition
1 sponsor
12 locations
NCT04279847
Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
PHASE1
Active, not recruiting
140 participants
Started: Feb 23, 2021 · Completed: Dec 30, 2026
7 conditions
1 sponsor
48 locations
NCT04913415
A Study to Evaluate Routine Chest Tube Management After Minimally Invasive Lung Surgery
NA
Active, not recruiting
160 participants
Started: Feb 23, 2021 · Completed: Aug 31, 2024
1 condition
1 sponsor
1 location
NCT03899636
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
PHASE3
Active, not recruiting
528 participants
Started: Feb 23, 2021 · Completed: Apr 30, 2025
1 condition
1 sponsor
6 locations
NCT04255849
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
PHASE3
Active, not recruiting
700 participants
Started: Feb 23, 2021 · Completed: Jan 31, 2026
3 conditions
8 sponsors
3 locations
NCT04685135
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
PHASE3
Active, not recruiting
453 participants
Started: Feb 23, 2021 · Completed: Jul 2, 2026
2 conditions
1 sponsor
343 locations
NCT04736199
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
PHASE3
Active, not recruiting
669 participants
Started: Feb 23, 2021 · Completed: Jan 30, 2026
1 condition
2 sponsors
131 locations
NCT04704219
Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)
PHASE2
Active, not recruiting
160 participants
Started: Feb 23, 2021 · Completed: Oct 25, 2025
1 condition
2 sponsors
56 locations
NCT04644575
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A
PHASE3
Active, not recruiting
261 participants
Started: Feb 23, 2021 · Completed: Jan 15, 2027
1 condition
1 sponsor
85 locations
NCT05426447
Protein and Performance (PROPER) in Endurance Athletes
NA
Active, not recruiting
20 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT04721015
Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors
PHASE1
Active, not recruiting
81 participants
Started: Feb 23, 2021 · Completed: Feb 28, 2026
2 conditions
1 sponsor
33 locations
NCT04408638
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
PHASE3
Active, not recruiting
270 participants
Started: Feb 23, 2021 · Completed: Feb 15, 2026
1 condition
1 sponsor
62 locations
NCT04208490
Implementation and Effectiveness Trial of HN-STAR
NA
Active, not recruiting
357 participants
Started: Feb 23, 2021 · Completed: Feb 28, 2027
1 condition
3 sponsors
49 locations
NCT04702373
Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT
PHASE3
Active, not recruiting
144 participants
Started: Feb 23, 2021 · Completed: Dec 30, 2024
1 condition
2 sponsors
10 locations
NCT04780659
COVID-19 Vaccination of Immunodeficient Persons (COVAXID)
PHASE4
Active, not recruiting
540 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04793269
Characteristics of Long COVID-19 Syndrome
N/A
Active, not recruiting
200 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04242823
Primary HPV-based Cervical Cancer Screening Algorithms in Botswana
NA
Active, not recruiting
3,000 participants
Started: Feb 22, 2021 · Completed: Feb 1, 2027
2 conditions
3 sponsors
1 location
NCT04347161
Implementation Strategies for Monitoring Adherence in Real Time
NA
Active, not recruiting
75 participants
Started: Feb 22, 2021 · Completed: Oct 20, 2025
3 conditions
3 sponsors
1 location
NCT04641026
Discovery of Biological Signatures for Cruciferous Vegetable Intake (Single Serving)
NA
Active, not recruiting
83 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04659707
Hyperpolarized 129Xe MRI of Survivors of COVID-19
PHASE1
Active, not recruiting
20 participants
Started: Feb 22, 2021 · Completed: May 1, 2025
1 condition
1 sponsor
1 location
NCT04564703
Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
PHASE2
Active, not recruiting
160 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2027
1 condition
3 sponsors
4 locations
NCT04567732
Bilateral Knee Osteoarthritis: Intra-articular Injection of Filtered Autologous Adipose Tissue Versus Placebo
NA
Active, not recruiting
100 participants
Started: Feb 22, 2021 · Completed: Apr 30, 2026
2 conditions
1 sponsor
1 location
NCT04746235
Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia
PHASE2
Active, not recruiting
85 participants
Started: Feb 22, 2021 · Completed: Oct 31, 2026
3 conditions
1 sponsor
1 location
NCT04808037
Blmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
66 participants
Started: Feb 22, 2021 · Completed: Nov 8, 2028
1 condition
2 sponsors
1 location
NCT04729322
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
PHASE2
Active, not recruiting
15 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2025
7 conditions
2 sponsors
1 location
NCT04696809
A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
40 participants
Started: Feb 22, 2021 · Completed: Apr 22, 2026
1 condition
1 sponsor
15 locations
NCT04697628
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
PHASE3
Active, not recruiting
502 participants
Started: Feb 22, 2021 · Completed: May 7, 2026
1 condition
2 sponsors
217 locations
NCT06332937
Breast Reconstruction
N/A
Active, not recruiting
5,000 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04286191
Physiological Changes Induced Through MEP Conditioning in People With SCI
NA
Active, not recruiting
44 participants
Started: Feb 22, 2021 · Completed: Nov 30, 2025
4 conditions
2 sponsors
1 location
NCT04750811
A Danish Audit of Small Bowel Obstruction
N/A
Active, not recruiting
540 participants
Started: Feb 22, 2021 · Completed: Mar 1, 2026
1 condition
1 sponsor
6 locations
NCT04688151
Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma.
PHASE1
Active, not recruiting
22 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2025
1 condition
5 sponsors
1 location
NCT04764682
Determining Molecular Drivers of Radiation Dermatitis
N/A
Active, not recruiting
20 participants
Started: Feb 21, 2021 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT04844385
Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
PHASE2
Active, not recruiting
124 participants
Started: Feb 20, 2021 · Completed: Dec 20, 2024
1 condition
1 sponsor
1 location
NCT04076410
Efficacy of Lenses in Abolishing Photoparoxysmal Responses
NA
Active, not recruiting
28 participants
Started: Feb 20, 2021 · Completed: Jan 31, 2026
2 conditions
2 sponsors
2 locations
NCT04477512
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
PHASE1
Active, not recruiting
18 participants
Started: Feb 19, 2021 · Completed: Sep 11, 2025
1 condition
3 sponsors
1 location
NCT04769960
Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy
N/A
Active, not recruiting
68 participants
Started: Feb 19, 2021 · Completed: Feb 19, 2026
3 conditions
1 sponsor
3 locations
NCT06865209
Monolithic Zirconia Posterior Single Crowns: a Randomized Clinical Trial.
NA
Active, not recruiting
50 participants
Started: Feb 19, 2021 · Completed: Jan 9, 2026
1 condition
1 sponsor
1 location
NCT04699786
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NA
Active, not recruiting
450 participants
Started: Feb 19, 2021 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
Previous
1
More pages
246
247
248
249
250
251
252
More pages
431
Next